North America In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity

Abstract
North America in vitro diagnostics (IVD) market is projected to grow by 5.6% annually in the forecast period and reach $ 54,000.3 million by 2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing.
Highlighted with 25 tables and 60 figures, this 131-page report “North America In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America in vitro diagnostics (IVD) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America in vitro diagnostics (IVD) market in every aspect of the classification from perspectives of Product, Technology, Sample Type, Application, End User, and Country.

Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Instruments & Devices
oDisposable IVD Devices
oReusable IVD Devices
•Reagents & Kits
•Software & Services

Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Clinical Chemistry
•Molecular Diagnostics
•Immuno Diagnostics
•Hematology
•Tissue Diagnostics
•Microbiology
•Coagulation and Hemostasis
•Urinalysis
•Other Technologies

By Sample Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Blood
•Mucus
•Urine
•Other Sample Types

By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Infectious Diseases
•Diabetes
•Cancer/Oncology
•Cardiology
•Autoimmune Disease
•Nephrology
•Drug Testing
•HIV/AIDS
•Other Applications

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Diagnostic Laboratories
•Hospitals and Clinics
•Homecare Settings
•Point-of-Care (POC) Settings
•Other End Users

Geographically, the following national/local markets are fully investigated:
•U.S.
•Canada
•Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Arkray Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
DiaSorin SpA (Luminex Corporation)
Epic Systems Corporation
F. Hoffmann-La Roche Ltd.
Genpact Limited
Grifols SA
IBM Corporation
Mckesson Corporation
Ortho Clinical Diagnostics Inc.
Qiagen NV
Quest Diagnostics Inc.
Quidel Corporation
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Content
Table of Contents

1 Introduction7
1.1 Industry Definition and Research Scope7
1.1.1 Industry Definition7
1.1.2 Research Scope8
1.2 Research Methodology11
1.2.1 Overview of Market Research Methodology11
1.2.2 Market Assumption12
1.2.3 Secondary Data12
1.2.4 Primary Data12
1.2.5 Data Filtration and Model Design13
1.2.6 Market Size/Share Estimation14
1.2.7 Research Limitations15
1.3 Executive Summary16
2 Market Overview and Dynamics19
2.1 Market Size and Forecast19
2.1.1 Impact of COVID-19 on World Economy20
2.1.2 Impact of COVID-19 on the Market24
2.2 Major Growth Drivers26
2.3 Market Restraints and Challenges32
2.4 Emerging Opportunities and Market Trends35
2.5 Porter’s Fiver Forces Analysis39
3 Segmentation of North America Market by Product43
3.1 Market Overview by Product43
3.2 Instruments & Devices45
3.2.1 Disposable IVD Devices46
3.2.2 Reusable IVD Devices47
3.3 Reagents & Kits48
3.4 Software & Services49
4 Segmentation of North America Market by Technology50
4.1 Market Overview by Technology50
4.2 Clinical Chemistry52
4.3 Molecular Diagnostics53
4.4 Immuno Diagnostics54
4.5 Hematology55
4.6 Tissue Diagnostics56
4.7 Microbiology57
4.8 Coagulation and Hemostasis58
4.9 Urinalysis59
4.10 Other Technologies60
5 Segmentation of North America Market by Sample Type61
5.1 Market Overview by Sample Type61
5.2 Blood63
5.3 Mucus64
5.4 Urine65
5.5 Other Sample Types66
6 Segmentation of North America Market by Application67
6.1 Market Overview by Application67
6.2 Infectious Diseases69
6.3 Diabetes79
6.4 Cancer/Oncology80
6.5 Cardiology81
6.6 Autoimmune Disease82
6.7 Nephrology83
6.8 Drug Testing84
6.9 HIV/AIDS85
6.10 Other Applications86
7 Segmentation of North America Market by End User87
7.1 Market Overview by End User87
7.2 Diagnostic Laboratories89
7.3 Hospitals and Clinics90
7.4 Homecare Settings91
7.5 Point-of-Care (POC) Settings92
7.6 Other End Users93
8 North America Market 2021-2031 by Country94
8.1 Overview of North America Market94
8.2 U.S.97
8.3 Canada100
8.4 Mexico102
9 Competitive Landscape104
9.1 Overview of Key Vendors104
9.2 New Product Launch, Partnership, Investment, and M&A107
9.3 Company Profiles108
Abbott Laboratories, Inc.108
Agilent Technologies, Inc.110
Arkray Inc.111
Becton, Dickinson and Company112
Biomerieux SA113
Bio-Rad Laboratories Inc.114
Danaher Corporation115
DiaSorin SpA (Luminex Corporation)116
Epic Systems Corporation117
F. Hoffmann-La Roche Ltd.118
Genpact Limited119
Grifols SA120
IBM Corporation121
Mckesson Corporation122
Ortho Clinical Diagnostics Inc.123
Qiagen NV124
Quest Diagnostics Inc.125
Quidel Corporation126
Roche Diagnostics127
Siemens Healthineers128
Sysmex Corporation129
Thermo Fisher Scientific Inc.130
RELATED REPORTS131List of Tables:

Table 1. Snapshot of North America In Vitro Diagnostics Market in Balanced Perspective, 2021-203117
Table 2. World Economic Outlook, 2021-203121
Table 3. World Economic Outlook, 2021-202322
Table 4. World Health Spending by Region, $ bn, 2013-202031
Table 5. Main Product Trends and Market Opportunities in North America In Vitro Diagnostics Market35
Table 6. North America In Vitro Diagnostics Market by Product, 2021-2031, $ mn43
Table 7. North America In Vitro Diagnostics Market: Instruments & Devices by Type, 2021-2031, $ mn45
Table 8. North America In Vitro Diagnostics Market by Technology, 2021-2031, $ mn50
Table 9. North America In Vitro Diagnostics Market by Sample Type, 2021-2031, $ mn61
Table 10. North America In Vitro Diagnostics Market by Application, 2021-2031, $ mn67
Table 11. Commercially Available COVID-19 Diagnostic Tests Approved in 2021-202270
Table 12. North America In Vitro Diagnostics Market by End User, 2021-2031, $ mn87
Table 13. North America In Vitro Diagnostics Market by Country, 2021-2031, $ mn95
Table 14. U.S. In Vitro Diagnostics Market by Product, 2021-2031, $ mn99
Table 15. U.S. In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn99
Table 16. U.S. In Vitro Diagnostics Market by End User, 2021-2031, $ mn99
Table 17. Canada In Vitro Diagnostics Market by Product, 2021-2031, $ mn101
Table 18. Canada In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn101
Table 19. Canada In Vitro Diagnostics Market by End User, 2021-2031, $ mn101
Table 20. Mexico In Vitro Diagnostics Market by Product, 2021-2031, $ mn103
Table 21. Mexico In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn103
Table 22. Mexico In Vitro Diagnostics Market by End User, 2021-2031, $ mn103
Table 23. Abbott Laboratories, Inc.: Company Snapshot108
Table 24. Abbott Laboratories, Inc.: Business Segmentation109
Table 25. Abbott Laboratories, Inc.: Product Portfolio109